These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 1462834

  • 21. Effects of long-term erythropoietin therapy on fibrinolytic system in haemodialyzed patients.
    Pawlak K, Pawlak D, Mysliwiec M.
    Thromb Res; 2008; 121(6):787-91. PubMed ID: 17869326
    [Abstract] [Full Text] [Related]

  • 22. Fibrinolytic and haemostatic responses to desamino-D-arginine vasopressin (DDAVP) administered by intravenous and subcutaneous routes in healthy subjects.
    MacGregor IR, Roberts EM, Prowse CV, Broomhead AF, Ozolins M, Litka P.
    Thromb Haemost; 1988 Feb 25; 59(1):34-9. PubMed ID: 3129807
    [Abstract] [Full Text] [Related]

  • 23. Factor XII-induced fibrinolysis. Diminished proactivator activity and drastic reduction of activator activity in Fletcher factor-deficient plasma gamma globulin.
    Espana F, Aznar J, Estelles A.
    J Lab Clin Med; 1982 Nov 25; 100(5):756-70. PubMed ID: 6182261
    [Abstract] [Full Text] [Related]

  • 24. Blood fibrinolysis and the response to desmopressin in glomerulonephritis.
    Brommer EJ, Van den Wall Bake AW, Dooijewaard G, van Loon BJ, Emeis JJ, Weening JJ.
    Thromb Haemost; 1994 Jan 25; 71(1):19-25. PubMed ID: 8165642
    [Abstract] [Full Text] [Related]

  • 25. The effect of continuous-flow automated plateletpheresis on fibrinolytic activity of donor plasma.
    Radziwon P, Boczkowska-Radziwon B, Lipska A, Smoktunowicz M, Kloczko J.
    Transfus Med; 2005 Aug 25; 15(4):319-22. PubMed ID: 16101810
    [Abstract] [Full Text] [Related]

  • 26. Evaluation of fibrinolytic capacity by a combined assay system for tissue-type plasminogen activator antigen and function using monoclonal anti-tissue-type plasminogen activator antibodies.
    Wojta J, Turcu L, Wagner OF, Korninger C, Binder BR.
    J Lab Clin Med; 1987 Jun 25; 109(6):665-71. PubMed ID: 3108431
    [Abstract] [Full Text] [Related]

  • 27. Normal tissue plasminogen activator and plasminogen activator inhibitor activity in plasma from patients with type 1 diabetes mellitus.
    Vicari AM, Viganó D'Angelo S, Testa S, Comi G, Galardi G, Orsi E, D'Angelo A.
    Horm Metab Res; 1992 Nov 25; 24(11):516-9. PubMed ID: 1452117
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Oxidative stress effects fibrinolytic system in dialysis uraemic patients.
    Pawlak K, Pawlak D, Mysliwiec M.
    Thromb Res; 2006 Nov 25; 117(5):517-22. PubMed ID: 15964061
    [Abstract] [Full Text] [Related]

  • 31. Fibrin-specific thrombolytic agents.
    Collen D.
    Klin Wochenschr; 1988 Nov 25; 66 Suppl 12():15-23. PubMed ID: 3126344
    [Abstract] [Full Text] [Related]

  • 32. Urokinase-type plasminogen activator-induced monocyte adhesion is modulated by kininogen, kallikrein, factor XII, and plasminogen.
    Li C, Gurewich V, Liu JN.
    Exp Cell Res; 1996 Aug 01; 226(2):239-42. PubMed ID: 8806427
    [Abstract] [Full Text] [Related]

  • 33. 1-Desamino-8-D-arginine vasopressin (DDAVP) in patients with congenital nephrogenic diabetes insipidus.
    Brink HS, Derkx FH, Boomsma F, Brommer EJ, Schalekamp MA.
    Neth J Med; 1993 Aug 01; 43(1-2):5-12. PubMed ID: 8232694
    [Abstract] [Full Text] [Related]

  • 34. Fibrinolytic response to interferon-alpha in healthy human subjects.
    Corssmit EP, Levi M, Hack CE, ten Cate JW, Sauerwein HP, Romijn JA.
    Thromb Haemost; 1996 Jan 01; 75(1):113-7. PubMed ID: 8713789
    [Abstract] [Full Text] [Related]

  • 35. Plasminogen activator inhibitor type-1 determines plasmin formation in patients with ischaemic heart disease.
    Pedersen OD, Gram J, Jespersen J.
    Thromb Haemost; 1995 May 01; 73(5):835-40. PubMed ID: 7482412
    [Abstract] [Full Text] [Related]

  • 36. On the role of C1-inhibitor as inhibitor of tissue-type plasminogen activator in human plasma.
    Huisman LG, van Griensven JM, Kluft C.
    Thromb Haemost; 1995 Mar 01; 73(3):466-71. PubMed ID: 7667830
    [Abstract] [Full Text] [Related]

  • 37. Renal and hepatic handling of endogenous tissue-type plasminogen activator (t-PA) and its inhibitor in man.
    Brommer EJ, Derkx FH, Schalekamp MA, Dooijewaard G, vd Klaauw MM.
    Thromb Haemost; 1988 Jun 16; 59(3):404-11. PubMed ID: 3142078
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Haemostasis in oral surgery--the possible pathogenetic implications of oral fibrinolysis on bleeding. Experimental and clinical studies of the haemostatic balance in the oral cavity, with particular reference to patients with acquired and congenital defects of the coagulation system.
    Sindet-Pedersen S.
    Dan Med Bull; 1991 Dec 16; 38(6):427-43. PubMed ID: 1802633
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.